​

Funding Round

Series B - Pherecydes Pharma

Series B - Pherecydes Pharma

Investment Firm

Overview

Pherecydes Pharma Operator of an innovative biotechnologies company created to develop personalized phage therapy.

Announced Date

Jan 16, 2018

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

GO CAPITAL

GO CAPITAL

GO CAPITAL is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorFaDièse
Participant InvestorGO CAPITAL
Participant InvestorAuriga Partners
Participant InvestorOmnes Capital
Participant InvestorKarista

Round Details and Background

Pherecydes Pharma raised $10675921 on 2018-01-16 in Series B

Pherecydes Pharma Operator of an innovative biotechnologies company created to develop personalized phage therapy.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 18, 2012
Grant - Pherecydes Pharma
-1.2M
Mar 18, 2015
Venture Round - Pherecydes Pharma
2-2.7M
Jan 03, 2022
Grant - Pherecydes Pharma
1-2.3M
Dec 01, 2014
Series A - Pherecydes Pharma
2-2.4M

Recent Activity

There is no recent news or activity for this profile.